| 1 |
Hemoglobin Disease Study Group. Survey of human hemoglobin of 600 000 cases in 20 provinces，cities，autonomous[J]．Chin J Med, 1983，63：382-385.
|
| 2 |
Institute of Hematology, Chinese Academy of Medical Sciences, Hemoglobin Disease Study Group of 18 Provinces(Cities, Areas)．Analysis of the abnormal hemoglobin in China[J]．Chin J Med，1986，66：462-464.
|
| 3 |
Xu XM, Zhou YQ, Luo GX, et al. The prevalence and spectrum of αand β-Thelassemia in Guangdong province: Implications for the future health burden and population screening[J]. J Clin Pathol, 2004，57：517-522.
|
| 4 |
Li CG, Li CF, Li Q, et al. Thalassemia incidence and treatment in children with special reference to Shenzhen city and Guangdong province[J]. Hemoglobin, 2009，33：296-303.
|
| 5 |
Zhao ZM, Yao LQ, Fan LM, et al.Epidemilolgy investigation of Thalassemia of six national 0-7 years old children in Yunnan province environmental state on both sides[J]．Chin J Epidemiolog，2011，32：352-356.
|
| 6 |
Ministry of Health of the People's Republic of China. Maternal and child health care and community health work in 2012[R].2012，6：1-3.
|
| 7 |
Fang JP, Xu LH. Criteria of diagnosis and treatment of Thalassemia[J]．Chin J Pediatr，2010，48：166-169.
|
| 8 |
Huang SL, Fang JP, Zhou DH, et al.Treatment of severe β-Thalassemia by transplantation of umbilical cord blood hematopoietic stem cell[J]．Chin J Pediatr，1998：671-674.
|
| 9 |
Zhu WG, Li XX, Yang M, et al. Treatment of severe β-Thalassemia by bone marrow trasplantation[J]．Chin J Pediatr，2000：320-322.
|
| 10 |
Fang JP, Chen C, Huang SL, et al. Treatment of severe β-Thalassemia by allogeneic peripheral blood hematopoietic stem cell transplantation[J]．Chin J Pediatr，2000：560-563.
|
| 11 |
Li C, Wu X, Feng X, et al. A novel conditioning regimen improves outcomes in β-thalassemia major patients using unrelated donor perioheral blood stem cell transplantation[J]. Blood, 2012，120：3875-3881.
|
| 12 |
WHO. Global applications of genomics in healthcare: Cyprus/Sardinia. Genomics and world health[R]．Sumner Geneva Switzerland, WHO, 2002, 12，1-6.
|
| 13 |
Kalokairinou EM. The experience of beta-Thalassemin and its prevention in Cyprus[J]. Med Law, 2008，27：825-841.
|
| 14 |
Ministry of Health of the People's Republic of China. Maternal and child health care and community health work in 2012[R].2012, 9：1-6.
|
| 15 |
Zhou YQ, Li WD, Xu XM.The labolatory techniques for the screering of hereditary hemoglobinpathies[J]. Int J Genet，2008，31：17-22.
|
| 16 |
Urrechaga E. High-resolution HbA/C separation and hemoglobinpathy detection with capillary eletropheresis[J]. Am J Clin Pathol, 2012，138：448-456.
|
| 17 |
Urrechaga E, Borque L, Escanero JF. The role of automated measurement of red cell subpopulation on in differential diagnosis of microcytic anemia and β-Thalassemia screening[J]. Am J Clin Pathol，2011，135：374-379.
|
| 18 |
Bouva MJ, Sollaino C, Perseu L, et al. Relationship between neonatal screening results by HPLC and the number of α-Thalassemia gene mutation consequences for the cut-off value[J]. J Med Screen，2011，18：182-186.
|
| 19 |
Du CS. The present states and the future of the research of Thalassemia[J]. Chin J Genet，1996, 10：5-6
|
| 20 |
Cheung MC, Goldberg JD, Kan YW. Prenatal diagnosis of sickle cell anemia and Thalassemia by analysis of fetal cell in maternal blood[J]. Nat Genet 1996, 14：264-268.
|
| 21 |
Di Naro E, Ghezzi F, Vitucci A, et al. Prenatal diagnosis of beta-Thalassemia using fetal erythroblast enriched from maternal blood by novel gradient[J]. Mol Hum Reprod, 2000，6：571-574.
|
| 22 |
Xue JS, Long GF. Separation of the fetal nucleated erythrocyte from maternal blood and the noninvasive prenatal diagnosis[J]. Chin J Hematol，2000, 21: 512-516.
|
| 23 |
Wei HY, Long GF, Lin WX, et al. The application of the fetal mononucleated erythrocyte from maternal peripheral blood in the prenatal diagnosis of β-Thalassemia[J]. Chin J Pediatr, 2007，45：917-921
|
| 24 |
Lo YM, Corbetta N, Chamberlain PF, et al. Presence of fetal DNA in maternal plasma and serum[J]. Lancet, 1997, 350：485-487.
|
| 25 |
Lo YM, Chiu RW. Noninvasive approaches to prenatal diagnosis of hemoglobinopathies using fetal DNA in plasma[J]. Hemotol Oncol Clin North Am, 2010, 24: 1179-1186.
|
| 26 |
Lam KW, Jiang P, Liao GT, et al. Noninvasive prenatal diagnosis of monogenic diseases by targeted massively parallel sequencing of maternal plasma: Application to β-Thalassemia[J]. Clin Chem, 2012, 58：1467-1475.
|
| 27 |
Palmer GA, Traeger-Synodinos J, Davies S, et al. Pregnancies following blastocyst stage transfer in PGD cycles at risk for β-Thalassemic hemoglobinopathies[J]. Hum Reprod, 2002，17：25-31.
|